Cunde Medical Technology Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
63
- Latest Deal Type
-
Series A
- Investors
-
11
Cunde Medical Technology General Information
Description
Developer of biopharmaceutical products designed for cancer and advanced liver cirrhosis. The company offers personalised tumour vaccines, autologous dendritic cell therapies, peptide-drug conjugates, topical peptide ointments, and immune microenvironment modulation platforms, thereby enhancing immune response, inhibiting tumour growth, and reducing recurrence through targeted and innovative treatment approaches.
Contact Information
Website
www.cunde.comCorporate Office
- Room 201, Building 12, Tianfu Life Science Park
- Number 88 Keyuan South Road, High-tech Zone
- Chengdu, Sichuan 610093
- China
Corporate Office
- Room 201, Building 12, Tianfu Life Science Park
- Number 88 Keyuan South Road, High-tech Zone
- Chengdu, Sichuan 610093
- China
Cunde Medical Technology Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC (Series A) | 22-Sep-2025 | Completed | Generating Revenue | |||
| 7. Later Stage VC | Completed | Generating Revenue | ||||
| 6. Later Stage VC | 09-Aug-2022 | Completed | Generating Revenue | |||
| 5. Early Stage VC | 27-Oct-2021 | Completed | Generating Revenue | |||
| 4. Early Stage VC | 09-Jun-2020 | Completed | Generating Revenue | |||
| 3. Early Stage VC | 26-Nov-2019 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 27-Dec-2018 | $5.07M | $5.07M | Completed | Generating Revenue | |
| 1. Corporate | 07-Nov-2016 | Completed | Generating Revenue |
Cunde Medical Technology Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Cunde Medical Technology Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Cunde Medical Technology Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Guangdong Dongna Private Equity Fund Management | Venture Capital | Minority | ||
| Fangxin Capital | Venture Capital | Minority | ||
| Hongshan Group | Corporation | Minority | ||
| TusStar Incubator | Accelerator/Incubator | Minority | ||
| Korea Investment Partners | Venture Capital | Minority |
Cunde Medical Technology FAQs
-
When was Cunde Medical Technology founded?
Cunde Medical Technology was founded in 2016.
-
Where is Cunde Medical Technology headquartered?
Cunde Medical Technology is headquartered in Chengdu, China.
-
What is the size of Cunde Medical Technology?
Cunde Medical Technology has 63 total employees.
-
What industry is Cunde Medical Technology in?
Cunde Medical Technology’s primary industry is Drug Discovery.
-
Is Cunde Medical Technology a private or public company?
Cunde Medical Technology is a Private company.
-
What is Cunde Medical Technology’s current revenue?
The current revenue for Cunde Medical Technology is .
-
How much funding has Cunde Medical Technology raised over time?
Cunde Medical Technology has raised $15.7M.
-
Who are Cunde Medical Technology’s investors?
Guangdong Dongna Private Equity Fund Management, Fangxin Capital, Hongshan Group, TusStar Incubator, and Korea Investment Partners are 5 of 11 investors who have invested in Cunde Medical Technology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
